Description
Developer of a dialysis disinfection device designed to reduce infectious complications associated with catheter connections. The company's device uses proprietary UV technology to keep patients healthy and protected from infection while minimizing dependence on user compliance, enabling healthcare providers to improve dialysis patients' quality of life by reducing infections.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
11. Later Stage VC (Series A) | 23-Jun-2020 | $471K | 00.000 | 000.00 | Completed | Generating Revenue |
10. Grant | 01-Feb-2020 | 000 | 00.000 | Completed | Generating Revenue | |
9. Grant | 01-Jan-2020 | 00000 | 00.000 | Completed | Generating Revenue | |
8. Accelerator/Incubator | 01-Jan-2017 | 00.000 | Completed | Generating Revenue | ||
7. Grant | 01-Jan-2017 | 00000 | 00.000 | Completed | Generating Revenue | |
6. Later Stage VC (Series A1) | 31-Jan-2016 | 000 | 00.000 | 0000 | Completed | Generating Revenue |
5. Grant | 02-Jun-2015 | 00.000 | 00000 | Completed | Generating Revenue | |
4. Early Stage VC (Series A) | 06-May-2013 | 00000 | 00000 | 00.000 | Completed | Startup |
3. Grant | 01-Jan-2012 | $500K | Completed | Startup | ||
2. Grant | 01-Jan-2011 | $150K | Completed | Startup |
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A1 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series A | 0,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-3157269-A1 | Point of care ultraviolet disinfection system | Pending | 04-Oct-2019 | 00000000 | |
EP-4034220-A1 | Point of care ultraviolet disinfection system | Pending | 04-Oct-2019 | 00000000 | |
US-20210113725-A1 | Point of care ultraviolet disinfection system | Pending | 04-Oct-2019 | 00000000 | |
EP-3941563-A1 | Needleless connector valve for uv disinfection | Pending | 22-Mar-2019 | 000000000 | |
EP-3941563-A4 | Needleless connector valve for uv disinfection | Pending | 22-Mar-2019 | A61M39/16 | 0 |
Name | Representing | Role | Since |
---|---|---|---|
Julia Rasooly | PuraCath Medical | Founder, Chief Executive Officer, President & Board Member | 000 0000 |
Michael Rasooly | Self | Board Member | 000 0000 |
Richard Ferrari | Self | Board Member | 000 0000 |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Gregory Schears | Angel (individual) | Minority | 000 0000 | 000000 0 | |
Richard Ferrari | Angel (individual) | Minority | 000 0000 | 000000 0 | |
TransPacific Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
National Institutes of Health | Government | 000 0000 | 000000 0 | ||
QB3 | Accelerator/Incubator | 000 0000 | 000000 0 |